Diabetes has been on the rise for a while because of both the aging of the U.S. population -- as well as expanding waistlines. According to the National Diabetes Statistics Report, 37.3 million people in the United States have diabetes, and 96 million in the U.S. have pre-diabetes, including 48.8% of the population that is 65 or older.

A recent report by Global Market Insights puts the compound annual growth rate for the diabetes care devices market at 10% between now and 2030, becoming an $88 billion market by that time.

DexCom (NASDAQ: DXCM), Medtronic (NYSE: MDT) and Abbott Laboratories (NYSE: ABT), three of the largest manufacturers of continuous glucose monitoring management systems (CGMs) for diabetes care, are healthcare companies that are well-positioned to benefit from the growing number of people with diabetes worldwide.

Continue reading

Source Fool.com